The Effect of Platelet-rich Fibrin on Clinical and Patient-centered Outcomes of Third Molar Extractions

Not Applicable

Completed

• Conditions: Oral Surgery
• Interventions: Procedure: Third-molar extraction using platelet-rich fibrin as a filling of the alveolus

• Registration Number: NCT05089812
• Lead Sponsor: Medical University of Graz

Brief Summary

The fear of oral surgeries is mostly dedicated to pain and swelling in the following days. It is not surprising, that it is of high interest to do anything to reduce these consequences. Maybe this is a reason, why using platelet concentrates in oral health rehabilitation has become common in the last couple of years. Less swelling, less pain, quicker healing. The aims of the present study are to determine the effect of a platelet rich fibrin on postsurgical inflammatory complications and patient-centred outcomes and perceptions, in patients undergoing third molar extractions by split mouth technique.

25 medically healthy adults will be assigned to one of 2 groups (1 test- and 1 control group). This means due to the split mouth technique patients undergo a third molar extraction twice. The first time the patient will be randomly assigned to the test- or control group and the second time the patient will be in the other group (test or control group).

The test groups socket will be filled with a PRF (platelet-rich fibrin)-Clot before suturing the wound during third molar surgery. As well, a blood count and coagulations values will be determined. The control group will be operated conventionally. Swelling will be measured at day 1, 3 and 7 post surgery by CBCT (cone-beam computed tomography) facial scan. Subjects will be examined clinically by examiners at the seventh day after surgery for postoperative complications. In addition, Visual analogue scores (VAS) on pain, swelling and bleeding will be obtained from the patients from day 0 through day 7. The present study will answer an important clinical question with regards to the recommendation of platelet-rich fibrin usage to prevent post-operative complications with third molar surgery and to recommend a platelet-rich fibrin, if required.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-10-01
• Study First Submitted: 2021-10-11
• Study First Submitted QC: 2021-10-11
• Study First Posted: 2021-10-22
• Primary Completion: 2022-12-31
• Study Completion: 2024-03-30
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-26
• Last Update Posted: 2024-06-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

• Medically healthy adult [ASA (American Society of Anesthesiologists) classification I-II], age ≥ 16 years old
• Preferably non-smoker, or previous smoker (quit ≥ 5 years), light smoker with less than 20 cigarettes/ day
• Therapeutic or strategic indications
• No allergies against local anasthesia (Articain, Mepivacain) and their preservatives (Natriummetabisulfid E223, natriumchlorid)
• Written consent of the patient
• No infected upper and lower third molars
• Third molars in 4 quadrants and located in maxilla/mandible (classification of Pell and Gregory/ Winter) and indication for extractions

Exclusion Criteria

• Medically compromised subjects (ASA classification III-V)
• General contraindications against third molar extractions (e.g. immunodeficiency, advanced systemic diseases, corticosteroid medication)
• Treatment or diseases that may have an effect on bone turnover or bone or non-mineralized tissue metabolism (e.g. Bisphosphonates or local radio-therapy)
• Patients with anticoagulant therapy
• Heavy smoker or previous heavy smoker (quit < 5 years; ≥ 20 cigarettes/day)
• Use of any form of antibiotics in the last 3 months or subjects requiring antibiotic prophylaxis prior to dental treatment
• Pregnant or breast feeding. Self declared intend to conceive. A pregnancy test performed for female patients.
• Subjects aged < 16 years old

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control-Group	Third-molar extraction using platelet-rich fibrin as a filling of the alveolus	-
Test-Group	Third-molar extraction using platelet-rich fibrin as a filling of the alveolus	PRF-Group

Primary Outcome Measures

Name	Time	Method
Change in Swelling	Pre-surgical and at day 1, 3, 7 and 14 post-surgical	Buccal swelling will be measured manually as well as within creating a 3D face scan pre-surgical and at day 1, 3, 7 and 14 post-surgical. Scans will be superimposed and compared with Romexis software. Manual measurement: Lines between lateral corner of the eye- jaw angle, Tragus- outer Mouth corner, Tragus-Pogonion will be measured in mm and be compared pre-surgical and at day 1, 3, 7 and 14 post-surgical. longer lines suggest more swelling and a worse outcome.

Secondary Outcome Measures

Name	Time	Method
Change in Inflammatory Complications - VAS Swelling	Pre-surgical and at day 1, 3, 7 and 14 post-surgical	VAS-Scale day 1-7 (Swelling). Scale from 0-10 (0 is no swelling/good outcome, 10 is a very high amount of swelling/bad outcome)
Change in Inflammatory Complications - VAS Pain	Pre-surgical and at day 1, 3, 7 and 14 post-surgical	VAS-Scale day 1-7 (pain) (0 is no pain/good outcome, 10 is a very bad pain/bad outcome)
Change in Inflammatory Complications - Amount of clinical recordings	Pre-surgical and at day 1, 3, 7 and 14 post-surgical	Clinical recordings of post-surgical inflammatory complications (like issue of purulent matter, restriction of the opening of the mouth, clinical attachment loss of second molar distal, flap closure)
Change in Inflammatory Complications - VAS Bleeding	Pre-surgical and at day 1, 3, 7 and 14 post-surgical	VAS-Scale day 1-7 (Bleeding) (0 is no bleeding/good outcome, 10 is a very high amount of bleeding/bad outcome)

Trial Locations

Locations (1)

Medical University of Graz; 🇦🇹 Graz, Styra, Austria